APLS
Apellis·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
APLS fundamentals
Apellis (APLS) released its earnings on Oct 30, 2025: revenue was 458.60M (YoY +132.99%), beat estimates; EPS was 1.67 (YoY +463.04%), beat estimates.
Revenue / YoY
458.60M
+132.99%
EPS / YoY
1.67
+463.04%
Report date
Oct 30, 2025
APLS Earnings Call Summary for Q3,2025
- FDA Approval Milestone: EMPAVELI now treats 5,000+ rare kidney disease patients, with 152 patient starts in first 2 months.
- Revenue Resilience: $459M Q3 revenue (including $275M Sobi payment), SYFOVRE net $151M despite 4% injection growth headwinds.
- Growth Drivers: Prefilled syringe for SYFOVRE and FSGS/DGF trials set to launch, targeting $475M cash runway.
- Key Risks: Free goods usage ($40M headwind) and limited patient access programs constrain GA adoption.
- Strategic Wins: EMPAVELI's C3 targeting outperforms competitors, with 52% GA market share and 19/20 top nephrology accounts engaged.
EPS
Revenue
Revenue & Expenses
APLS has released its 2025 Q3 earnings report, with revenue of 458.58M, reflecting a YoY change of 132.98%, and net profit of 215.72M, showing a YoY change of 475.52%. The Sankey diagram below clearly presents APLS's revenue sources and cost distribution.
Key Indicators
Apellis (APLS) key financial stats and ratios, covering profitability, financial health, and leverage.
Apellis (APLS)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Apellis (APLS)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Apellis (APLS)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Apellis (APLS) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Apellis (APLS) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What guidance did Apellis's management provide for the next earnings period?What is Apellis's gross profit margin?What is the market's earnings forecast for Apellis next quarter?What were the key takeaways from Apellis's earnings call?What were the key takeaways from Apellis’s earnings call?What factors drove the changes in Apellis's revenue and profit?Did Apellis beat or miss consensus estimates last quarter?What does Apellis do and what are its main business segments?
